chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received incorrect dosage of vaccine (Peds Bivalent Maroon 6mo-4yrs)
COVID Arm.  Red, swollen, circumfrence of around 2-3 inches.  Slight itchiness.  Slight pain.
Immediately following injection donor had 8 sec seizure. When donor came to he was confused and nauseated. Donor helped to exam bed where NS 400 cc was administered via 20g catheter WO. Vital were obtained. 70/40 B/P 100 pulse. Vitals brought to 100/50 B/P 94 pulse. Donor refused transport to hospital. LE for 12-18-13 on 12-19-13. Donor did not hydrate well prior to coming in per donor.
5 days after receiving COVID booster, inflammation of Left breast in me (65 year old woman)  including redness, pain and swelling.  5 Days after symptoms developed, I was examined by Gynecologist and  mastitis was diagnosed and treated with antibiotics.
Fever x 3 days starting the night after vaccines with increasing fatigue and proximal muscle weakness leading to rheumatology referral and hospital admission x 2wks with pending inpatient rehabilitation. Per 60 day follow up: Patient was diagnosed with a myopathy, likely unrelated to vaccines as symptoms preceded vaccination.
Sore arm, body aches, chills, headache. By 48 hours most of the symptoms had faded to very minor. Exhausted within hours of the shot.
This spontaneous report as received from a nurse refers to a patient of unknown age. The patient was vaccinated with unspecified doses of GARDASIL series on 23-JUN-2011, 23-AUG-2011 and 23-DEC-2011. On 29-AUG-2015, the patient received an unspecified dose of GARDASIL 9 (lot# L007560 and 15-JUN-2017). No adverse effects were reported. Additional information has been requested.
Patient developed "itchy bump" on right upper arm in evening 10/14/15. Treated by mom with oral and topical BENADRYL. On 10/15/15 at school area enlarged over day and mom brought in for check at 2:30 pm. 5.5 x 7 cm induration at GARDASIL 9 site. Rx for oral prednisolone for 5 day course and OTC Hydrocortisone cream to area.
That evening, 2/17/21, I got home ate some soup in bed  soon after, slept 10 hours! The next morning went to work and then around 9:30 the chills started, checked my temp 99.8  decided to take myself home, at took temp again, 101.7  then an hour later 102.7  where it remained for the rest of 2/18/21.  By the next morning no more chills and temp 97.6.  I do have a lingering headache on both sides of my head which meanders down my neck. The site of the injection is still sore and seems to have moved 3 inches down my arm. And there is also a lingering phlegm problem building up at the back of my throat.
6 patients were administered from expired doses; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (6 patients were administered from expired doses) in a 56-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 31-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (6 patients were administered from expired doses). At the time of the report, EXPIRED PRODUCT ADMINISTERED (6 patients were administered from expired doses) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   Date the vial was initially stored in the refrigerator on 17-Mar-2022 The vial did not undergo any temperature excursions  No concomitant medication were provided No treatment details were provided   Most recent FOLLOW-UP information incorporated above includes: On 01-Apr-2022: No New information On 01-Apr-2022: Patient demographics added
Red splotch on arm morning after vaccine,  still apparent three days later, sore Temperature day after vaccine of 101.1 degrees, two days later 99.9 degrees High level buzzing sound in ears Tiredness Achiness, especially in joints
Just a few hours after receiving the vaccine in the late afternoon of June 22, I began having flu-like symptoms including severe soreness in the injection area, fever to 100 degrees, nausea, severe body aches especially in my legs, and headache.  These slowly subsided by late on June 24.   Overnight on June 27, I was awakened by my left arm twitching in the tricep area.  It continues to twitch as I write this mid-morning on June 27.  If it continues for the next few days, I will have to see a doctor.   These adverse effects have made me decide against getting the second dose of the shingles vaccine.
Red, raised area - size of 50 cent piece on LD. Pt states itches, area hard.
Developed paresthesias of the R great toe within a few days of the 1st Gardasil vaccine. She now experiences intermittent paresthesias of the toes and hands. Developed irregular menses and severe dysmenorrhea 4 months after 1st Gardasil vaccine which is ongoing. Received 2nd Gardasil 11/5/07 and the 3rd 8/14/09. Developed migraines 9/08 and continues to have frequently migraine headaches, some of which are intractable for days. Has had syncopal events, hand tremors, personality changes, easy bruising, myalgias, chronic fatigue, problems with concentration, rashes, anxiety, insomnia and poor immunity with very frequent infections (mostly respiratory, but has swollen lymph nodes and urinary tract infections as well). All of these did not start until after the 1st Gardasil vaccine 4 years ago.
Vomiting, extreme dizziness and vertigo.  Patient's mother reports he was barely able to stand.
This patient was not vaccinated.  He was in contact with an active duty member that had recently been vaccinated with vaccinia.  The patient experienced nasea, emesis, fever, headache, lymphadenopathy and rash.  The rash appeared on his left temple, right elbow and right forearm.  Oral and intravenous antibiotics did not improve the rash.  PCR demonstrated vaccinia.  Improved with observation.
Rash, hives, swelling at injection site 6-7 hours after shot. Headache, nausea, fatigue, fever, dizziness, lethargy 24-36 hours after shot.
Information has been received from a nurse referring to a patient of unknown age and gender. No pertinent or historical conditions were reported. On 15-OCT-2015 the patient was inadvertently administered a dose of improperly stored M-M-R II (lot # L002873, expiration date 27-JAN-2017, strength, dose and route unknown). No adverse effects were reported. Additional information has been requested.
NO ADVERSE EVENT; FACILITY NOTIFIED THE PATIENT WAS 17 YEARS OLD AT TIME OF ADMINISTRATION REQUIRING A VAERS REPORT
Patient for unknown reasons finished her series with Janssen & Janssen, but started with mRNA
Killer headache feels like a migraine; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Mar-2021 and was forwarded to Moderna on 17-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Killer headache feels like a migraine) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer. Concomitant products included TAMOXIFEN for Breast cancer, PAROXETINE for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Killer headache feels like a migraine). At the time of the report, MIGRAINE (Killer headache feels like a migraine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided
Patient developed a fairly bad case of hives all over her.  She took Benadryl at around 2pm after we spoke with the nurse's advice line, which helped.  Hives were gone the next morning.
Intense itching and swelling at injection site. Lasted about  3-4 days, controlled with antihistamines
Reddened area left thigh 3"x3"; discomfort with walking per patient. Discussed use warm compresses, Tylenol for age/weight every 4-6 hours PRN.
noticed fever 10 days p/vax pt recv vax 19OCT97;T102R;no rash;APAP helped;doing fine 24hr later;
12/02/2010 pt c/o rash on back, rash has persisted and spread to abdomen. Rash still present 12/06/2010. 12/06/2010 seen by PMD who administered injection of cortisone and gave pt Rx for Medrol Dosepak.
Muscle pain; Tingling all over body; This case was reported by a pharmacist via call center representative and described the occurrence of tingling in a 77-year-old female patient who received Herpes zoster (Shingrix) (batch number 39KB3, expiry date 1st April 2022) for prophylaxis.   On 27th February 2020, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 27th February 2020, immediately after receiving Shingrix, the patient experienced tingling. On an unknown date, the patient experienced muscle pain. On an unknown date, the outcome of the tingling was not recovered/not resolved and the outcome of the muscle pain was recovered/resolved.   It was unknown if the reporter considered the tingling and muscle pain to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left arm. The patient started experiencing tingling all over the body right after getting the vaccine and it had still not resolved. Less than 2 months after vaccination, the patient experienced muscle pain and had recovered.  The pharmacist did not know when exactly the muscle pain started and resolved. No further details were provided.
Pain in her leg; She has to sleep every hour because of the pain in both legs; Soreness in her shoulder; This is a spontaneous report from a contactable consumer or other non hcp. A 50-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19-19 mRNA VACCINE, Formulation: Solution for injection, (Batch/Lot number was not reported)), via an unspecified route of administration on 19May2021 as unknown, single for covid-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced soreness in her shoulder. On 23May2021, the patient had pain in her leg, and she has to sleep every hour because of the pain in both legs. She stated experiencing soreness in her shoulder at first. Three days ago, she started experiencing pain in her leg. She looked it up on the internet and found that a lot of people have been experiencing the same effect. She added that she must sleep every hour because of the pain in both legs. She mentioned that she did some exercise, but nothing special. Did not report swelling. She stated "it's weird. The pain was going up and down. I started to "google" my symptoms" She stated being scared to death and worried. She was fine before getting the Pfizer BioNTech COVID-19 vaccine. Not clear if she already spoke to DSU. She mentioned speaking to someone and then said, "you are the first person". Therefore, I offered a warm-transfer to safety, but caller asked to e-submit. I asked for HCP information, but she did not provide. Caller mentioned she has an appointment with her doctor tomorrow. Caller stated, "your vaccine was not safe" "it's new, no one knows" "everyone tells you it's very safe, here it could ruin the people's lives". The outcome of the event arthralgia was not recovered, pain in extremity was not recovered, hypersomnia was unknown.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.
Patient with possible disseminated vaccinia on vaccine day 14.  Treated with diphenydramine and missed a day of work.
I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 on 12/21/2022 at a social event. I tested positive for COVID-19 on 12/26/2022. I contacted my provider and received a prescription (unknown).  I had a fever with watery eyes on 12/25/2022. I really thought I had a sinus infection. As of today, I still feel fatigued.
her left side of her face which was the site that she had the shot on, on her arm was swelling; she had the shot on, on her arm was swelling; it could be a swollen lymph node; This is a spontaneous report from a contactable consumer (patient). An 83-year-old female patient received her first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) Lot # EL8982, via an unspecified route of administration on 22Jan2021 at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient stated this morning on 23Jan2021 when she woke up her left side of her face which was the site that she had the shot on, on her arm was swelling and she was looking at all the paper work and it says it could be a swollen lymph node. Consumer stated, she asked a doctor about getting it and he said yes, is that the doctor you want.
Allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic reaction) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Allergic reaction). At the time of the report, HYPERSENSITIVITY (Allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported. No treatment was provided.
Nausea; loose stools different color than usual; loose stools different color than usual; This is a spontaneous report from a contactable consumer (patient herself).  This 69-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number not provided), via an unknown route in the right arm, on 03Mar2021 (at the age of 69-year-old) at single dose for COVID-19 immunisation, administered at hospital. No other vaccine was received in four weeks. Relevant medical history included allergy to sulfa, allergy to kiwi fruit and latex. Relevant concomitant medications included paracetamol (TYLENOL), levothyroxine, progesterone, and propranolol. On 04Mar2021 at 16:00, the patient developed nausea, loose stools different color than usual. The events were reported as non-serious. The patient was not treated for the events. Pre and Post-vaccination COVID tests were not done. The patient had not recovered from the events.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
PATIENT WAS RECEIVING THREE VACCINES. COVID-19 VACCINE WAS ADMINISTERED FIRST AND THEN THE FLUZONE FOLLOWED IN THE SAME ARM. SHE WAS THEN TO RECEIVE THE ZOSTER VACCINE IN THE OTHER ARM. AS THE PHARMACIST WAS SPEAKING TO THE PATIENT HE DIDN'T NOTICE THAT HE GRABBED ANOTHER COVID-19 VACCINE. A SECOND COVID-19 VACCINE WAS ADMINISTERED DURING THE SAME VISIT. AFTER REALIZING WHAT HAPPENED THE PHARMACIST ADMINISTERED THE ZOSTER VACCINE AND HAD THE PATIENT WAIT 15 MINUTES. THERE WERE NO ADVERSE EFFECTS REPORTED BY THE PAITENT. THE PATIENT RECEIVED A THIRD AND FOURTH DOSE OF COVID-19 VACCINE AT SAME VISIT BY ACCIDENT.
Patient began to experience flu like symptoms a few hours after the vaccine that lasted for a week. He also experienced a red welt below the injection site, in addition to a circular bruise at the actual injection site.
fever, body aches, headache at base of skull, shortness of breath all beginning on Thursday. Went to ER and was given pain meds, chest xray, and bloodwork.  Diarrhea began Thursday afternoon and continued until Sunday, began feeling very weak, went back to ER and was given IV fluids.
Swollen eyes, mouth, hands Labored breathing Kidney pain Elevated HR  Treated with benadryl and rescue inhaler
R09.02 HYPOXIA 3/27/2023 CHRONIC CHOLECYSTITIS R09.02 HYPOXIA 3/27/2023 HYPERLIPIDEMIA
Pt received vaccine, passed out and had a few convulsions, them immediately came to. Pt was layed down, talked to, then passed out and had convulsions again. Pt immediately came back to. 911 was called after first event.
fever 103 & rhinitis; no redness, swelling or warmth to inject site;
Seriousness criteria other medically significant (OMIC). Initial information received from a health care professional on 8/17/06. An 18 year old female pt received initial dose of Adacel, lot number C2457AA, Administered IM in the right deltoid, Menactra, lot number U1783AA, administered IM in the left deltoid, and Hepatitis B vaccine, administered IM in the left deltoid on 8/16/06 at 1:35PM. Five minutes later, the pt stated that she did not feel well and collapsed. As per the reporter, her skin was pasty gray, eyes wide open and fully dilated and glassy, extremities slightly convulsing, non responsive. The pts pulse was monitored and was regular. An ammonia inhalant was used to bring the pt to. After a few minutes, the pt was alert and oriented and her color was returning to normal. She was released to her father after 30 to 40 minutes and was stable upon discharge. She recovered from the events. This pt had previously experienced an extremely high fever, and screaming following the administration of diphtheria, tetanus and pertussis vaccine at the age of two months (reported in case 200602184).
Small maculo-papalar spot to anterior trunk which began to enlarge quickly. Then other lesions began to form to arms, shoulder, trunk and now legs. Mildly pruritus, scaly. Now lesions continuing to form even on 16th days after 1st lesion.
Respiratory failure with subsequent intubation and mechanical ventilation; seizure-like episodes status post boluses of antiepileptics and subsequent drip now discontinued and only on mild sedation; elevated troponin persistent tachycardia suspicious for myocarditis; underwent brief broad spectrum antibiotics course and now remains on acyclovir; single PRBC transfusion for possible dilutional anemia; time course from 03/32/23 to present date
Information has been received from a consumer concerning a male family member, now 10 years old, who experienced autism after receiving vaccines at age 2. The reporter could not specify which vaccines the child received and who manufactured them. It was unknown if the patients sought medical attention. Follow-up information has been received from a registered nurse who reported that the patient was vaccinated with MMR II before developing autism. Upon internal review, autism was determined to be an other important medical event. No further information is available. This is one of several reports received from the same source.
New Sudden onset of flashers, floaters, vision loss left eye.. with 2 intraretinal hemorrhages...
feels like she has the flu; joint pain; headache; fever; chills; feels nauseous; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (feels like she has the flu), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever) and CHILLS (chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included OMEPRAZOLE, ALPRAZOLAM (XANAX), GABAPENTIN, TRAMADOL, LAMOTRIGINE, ATORVASTATIN and LORATADINE (CLARITIN [LORATADINE]) for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (feels like she has the flu), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and NAUSEA (feels nauseous). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (feels like she has the flu), ARTHRALGIA (joint pain), HEADACHE (headache), PYREXIA (fever), CHILLS (chills) and NAUSEA (feels nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       .
Adult dose given to a 18-month-old; Adult dose given to a 18-month-old; This case was reported by a nurse via call center representative and described the occurrence of overdose in a 18-month-old female patient who received HAV (Havrix adult) (batch number 95DB2, expiry date unknown) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 28th February 2023, the patient received Havrix adult and Havrix Pre-Filled Syringe Device. On 28th February 2023, unknown after receiving Havrix adult and Havrix Pre-Filled Syringe Device, the patient experienced overdose and inappropriate age at vaccine administration. On an unknown date, the outcome of the overdose and inappropriate age at vaccine administration were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 28-FEB-2023 Reporter's Comment: A reporter called to inform that earlier that day an adult dose of Havrix was administered to an 18-month-old patient.  The vaccine administration facility was the same as primary reporter. The reporter consented to follow up. Additional Supportive Information: A reporter called to inform that earlier that day an adult dose of Havrix was administered to an 18-month-old patient, which led to overdose and inappropriate age at vaccine administration.
- Severe dizziness started on Sunday  1-31-2021, it would happen even when I am sitting down and moving my head around, if I stand it would be affecting my balance. - Severe to moderate body aches, chills,  and pain all over the body with tiredness. started 01-30-2021.  - Moderate to mild loss of taste. -Mild to moderate fever. - Severe to moderate headaches, increased eye pressure, and intermittent cuffing with minimal sputum which increases eye pain and headaches. - Sinus congestion with minimal running nose. - Sore Throat
arm pain/soreness; This is a spontaneous report from a non-contactable nurse reported for herself. A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK5730, expiry date unknown) via an unspecified route of administration on unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced arm pain/soreness on unspecified date. The outcome of the event arm pain/soreness was unknown.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a registered nurse refers to an unknown number of patients of unknown age and gender. The patients' pertinent medical history or concurrent conditions were not provided. On an unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL, (Lot # L018286 and expiry date on 13-APR-2017) (dose and route of administration were not provided). No adverse events were reported. This is one of several reports received from the same source. Additional information has been requested.